Thomas Reiter

1.0k total citations
33 papers, 692 citations indexed

About

Thomas Reiter is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Thomas Reiter has authored 33 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Nephrology and 6 papers in Surgery. Recurrent topics in Thomas Reiter's work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Parathyroid Disorders and Treatments (5 papers). Thomas Reiter is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Parathyroid Disorders and Treatments (5 papers). Thomas Reiter collaborates with scholars based in Austria, Germany and Spain. Thomas Reiter's co-authors include Martin Haas, Daniel Cejka, Rodrig Marculescu, Alois Gessl, Nicolas Kozakowski, Max Plischke, Wolfgang Winnicki, Diana Lebherz-Eichinger, Georg A. Roth and Hendrik Jan Ankersmit and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Thomas Reiter

32 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Reiter Austria 14 250 121 116 106 104 33 692
Arnold Strashun United States 17 32 0.1× 65 0.5× 204 1.8× 175 1.7× 96 0.9× 47 768
Anja Büscher Germany 16 476 1.9× 310 2.6× 10 0.1× 42 0.4× 98 0.9× 48 927
Taro Kariya Japan 15 48 0.2× 285 2.4× 15 0.1× 8 0.1× 46 0.4× 58 742
Xavier Setoaín Spain 16 54 0.2× 59 0.5× 27 0.2× 64 0.6× 112 1.1× 53 781
Richard S. A. Tindall United States 16 33 0.1× 103 0.9× 25 0.2× 5 0.0× 94 0.9× 29 1.3k
William H. Moretz United States 17 43 0.2× 45 0.4× 32 0.3× 17 0.2× 111 1.1× 46 627
R. D. Gunasekera United Kingdom 14 50 0.2× 55 0.5× 8 0.1× 8 0.1× 136 1.3× 24 728
M. Galeazzi Italy 16 54 0.2× 169 1.4× 9 0.1× 18 0.2× 58 0.6× 63 974
Sara Reis Teixeira Brazil 13 65 0.3× 137 1.1× 18 0.2× 9 0.1× 55 0.5× 49 579
Gabriel Granåsen Sweden 13 27 0.1× 35 0.3× 29 0.3× 35 0.3× 46 0.4× 36 592

Countries citing papers authored by Thomas Reiter

Since Specialization
Citations

This map shows the geographic impact of Thomas Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Reiter more than expected).

Fields of papers citing papers by Thomas Reiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Reiter. The network helps show where Thomas Reiter may publish in the future.

Co-authorship network of co-authors of Thomas Reiter

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Reiter. A scholar is included among the top collaborators of Thomas Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Reiter. Thomas Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freire, Raimundo, Wolfgang Winnicki, Thomas Reiter, et al.. (2022). Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron. Viruses. 14(6). 1181–1181. 3 indexed citations
2.
Reiter, Thomas, Ludwig Wagner, Martina Gaggl, et al.. (2021). COVID-19 serology in nephrology healthcare workers. Wiener klinische Wochenschrift. 133(17-18). 923–930. 5 indexed citations
3.
Reiter, Thomas, David O’Connell, Hermine Agis, et al.. (2021). Renal Expression of Light Chain Binding Proteins. Frontiers in Medicine. 7. 609582–609582. 3 indexed citations
4.
Jeryczynski, Georg, Marlies Antlanger, Franz Duca, et al.. (2021). First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience. ESMO Open. 6(2). 100065–100065. 9 indexed citations
5.
Demyanets, Svitlana, Alexandra Kaider, Ingrid Simonitsch‐Klupp, et al.. (2020). Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response. Annals of Hematology. 99(11). 2599–2609. 4 indexed citations
6.
Reiter, Thomas, et al.. (2020). Effect of Thyroid Hormones on Kidney Function in Patients after Kidney Transplantation. Scientific Reports. 10(1). 2156–2156. 14 indexed citations
7.
Doberer, Konstantin, Johannes Kläger, Guido A. Gualdoni, et al.. (2020). CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection. Transplantation. 105(2). 451–457. 71 indexed citations
8.
9.
Winnicki, Wolfgang, Gere Sunder‐Plassmann, Gürkan Sengölge, et al.. (2019). Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method. Scientific Reports. 9(1). 13783–13783. 32 indexed citations
10.
Antlanger, Marlies, Thomas Reiter, Alexandra Böhm, et al.. (2018). Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC Cancer. 18(1). 1008–1008. 19 indexed citations
11.
Bielesz, Bernhard, Thomas Reiter, Rodrig Marculescu, et al.. (2017). Calcification Propensity of Serum is Independent of Excretory Renal Function. Scientific Reports. 7(1). 17941–17941. 18 indexed citations
12.
Lebherz-Eichinger, Diana, Bianca Tudor, Hendrik Jan Ankersmit, et al.. (2017). Increased trefoil factor 2 levels in patients with chronic kidney disease. PLoS ONE. 12(3). e0174551–e0174551. 8 indexed citations
13.
Winnicki, Wolfgang, Harald Herkner, Matthias Lorenz, et al.. (2017). Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney International. 93(3). 753–760. 45 indexed citations
14.
Minarik, Tamas, et al.. (2016). The Importance of Sample Size for Reproducibility of tDCS Effects. Frontiers in Human Neuroscience. 10. 453–453. 139 indexed citations
15.
Lebherz-Eichinger, Diana, Bianca Tudor, Hendrik Jan Ankersmit, et al.. (2015). Trefoil Factor 1 Excretion Is Increased in Early Stages of Chronic Kidney Disease. PLoS ONE. 10(9). e0138312–e0138312. 19 indexed citations
16.
Lebherz-Eichinger, Diana, D Klaus, Thomas Reiter, et al.. (2014). Increased chemokine excretion in patients suffering from chronic kidney disease. Translational research. 164(6). 433–443.e2. 12 indexed citations
17.
Cejka, Daniel, Michael Weber, Danielle Diarra, et al.. (2014). Inverse association between bone microarchitecture assessed by HR-pQCT and coronary artery calcification in patients with end-stage renal disease. Bone. 64. 33–38. 32 indexed citations
18.
Reiter, Thomas, et al.. (2013). Innovative Approaches for an Interactive Stated-Choice Survey. Transportation Research Board 92nd Annual MeetingTransportation Research Board. 2 indexed citations
19.
Hecking, Manfred, Marlies Antlanger, Wolfgang Winnicki, et al.. (2012). Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials. 13(1). 79–79. 16 indexed citations
20.
Roth, Georg A., Diana Lebherz-Eichinger, Hendrik Jan Ankersmit, et al.. (2011). Increased total cytokeratin-18 serum and urine levels in chronic kidney disease. Clinica Chimica Acta. 412(9-10). 713–717. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnold Strashun Breakdown of academic impact, for papers by Anja Büscher Breakdown of academic impact, for papers by Taro Kariya Breakdown of academic impact, for papers by Xavier Setoaín Breakdown of academic impact, for papers by Richard S. A. Tindall Breakdown of academic impact, for papers by William H. Moretz Breakdown of academic impact, for papers by R. D. Gunasekera Breakdown of academic impact, for papers by M. Galeazzi Breakdown of academic impact, for papers by Sara Reis Teixeira Breakdown of academic impact, for papers by Gabriel Granåsen
Rankless by CCL
2026